Newsfeeds - Spark Newswire

2 minute read

Analyzing Allstate’s Short Interest

Today, 4:18 PM

Allstate's (NYSE:ALL) short percent of float has fallen 3.85% since its last report. The company recently reported that it has 3.44 million shares sold short, which is 1.25% of all regular shares that are available for trading.

ALL

2 minute read

Executives Sell Around $200M Of 5 Stocks

By Lisa Levin

Today, 4:18 PM

Gold futures traded higher this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades.

ALL

2 minute read

Elon Musk Weighs In On Gun Control, ‘Homicide Insurance’ Following Uvalde School Mass Shooting

By Melanie Schaffer

Today, 4:18 PM

In the wake of another mass shooting, this time at Robb Elementary School in Uvalde, Texas, where 19 students and two teachers were gunned down on Tuesday, Tesla Inc (NASDAQ:

ALL

1 minute read

Argus Research Downgrades Allstate to Hold

By Benzinga Newsdesk

Today, 4:18 PM

Argus Research analyst Kevin Heal downgrades Allstate (NYSE:ALL) from Buy to Hold.

ALL

2 minute read

Earnings

Allstate’s Return On Capital Employed Insights

By Benzinga Insights

Today, 4:18 PM

According to Benzinga Pro data Allstate (NYSE:ALL) posted a 18.33% decrease in earnings from Q4. Sales, however, increased by 4.47% over the previous quarter to $10.76 billion.

ALL

27 minute read

Earnings Scheduled For May 4, 2022

By Benzinga Insights

Today, 4:18 PM

Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.

ABC